恒指午後曾跌破26,100 惟蒙牛/药明生物/创科及科技股弹逾2%-4.5%
投资者重新权衡疫苗研发露曙光及环球疫情激增与经济反弹的可能时机，资金再次由旧经济股转投科技股，恒指昨天反覆回软结束四连涨後，今早在三大科技股急弹推动高开0.7%报26,409，进一步升至26,460无以为继，在金融及地产板块显着回吐拖累下，午後跌幅曾扩至155点，低见26,071，现造26,106，倒跌120点或0.5%，成交额1,323亿元。
内地10月新增贷款回落至6,898亿元人民币创一年低兼不及市场预期7,500亿人民币。四大蓝筹内银全部回吐，尤其是工行(01398.HK)及中行(03988.HK)由近四个月及四个月高位回落，最低见4.71元及2.75元，现造4.76元及2.76元，回吐2.7%及2.1%；建行(00939.HK)曾由近四个月高位回吐2.7%至6.02元获承接，现造6.11元，仅回吐1.3%。
汇控(00005.HK)今早高开进一步升至39.7元(受制7月初所造40元)，掉头低见38元，现造38元，倒跌2.5%，结束八连涨；旗下恒生(00011.HK)由逾四个高位回落，最低见129.2元，现造130.7元，回吐3.2%。此外，国寿(02628.HK)及友邦(01299.HK)分别吐逾1.5%及3.5%，低见17.74元及83.35元。不过，上季多赚52%胜预期获野村升价462.9元的港交所(00388.HK)由高位两连吐守稳百天线，今天股价曾重越50天及20天线(372.8元)，最高见375元，现造370.6元，回升1.4%。
地产收租股除恒隆地产(00101.HK)窄幅逆稳外，全部回吐逾1.5%-4%，新地(00016.HK)、新世界(00017.HK)、中海外(00688.HK)及润地(01109.HK)回吐压力最大，股价依次跌2.8%-4.2%，分别低见103.9元、39.6元、20.85元及36.7元。此外，中移动(00941.HK)及联通(00762.HK)回升受制牛熊线，今天股价吐逾3%及4%，分别低见51.15元及5.28元。
相反，阿里(09988.HK)、小米(01810.HK)及今天放榜腾讯(00700.HK)扭转连日捱沽颓势，股价随美国科技股反弹逾2%-4.5%，分别高见258.6元、24元及586元。此外，舜宇(02382.HK)、蒙牛(02319.HK)、创科(00669.HK)及药明生物(02269.HK)升近3%-4%，分别报149.3元/41.3元/101.3元/232.2元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
